Drugs / DopaCell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07572071 | Aug 2025 → Aug 2028 expected | Parkinson disease | Royan Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dopacell | “Biological: Dopacell” NCT07572071 ↗ |
| Modality | Cell therapy | “human embryonic stem cell-derived dopaminergic progenitor cells” NCT07572071 ↗ |
| Route | Other | “intraputaminal transplantation” NCT07572071 ↗ |